Northern Trust Corp Travere Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 678,037 shares of TVTX stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

678,037

Previous 704,562 3.76%

Holding current value

$12 Million

Previous $5.79 Million 63.79%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.89 - $15.21 $209,282 - $403,445	-26,525 Reduced 3.76%	678,037 $9.49 Million
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $102,396 - $161,186	-19,467 Reduced 2.69%	704,562 $5.79 Million
Q1 2024 May 14, 2024	SELL	$7.18 - $9.82 $43,920 - $60,068	-6,117 Reduced 0.84%	724,029 $5.58 Million
Q4 2023 Feb 13, 2024	BUY	$5.44 - $9.5 $218,285 - $381,197	40,126 Added 5.82%	730,146 $6.56 Million
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $44,976 - $101,550	5,887 Added 0.86%	690,020 $6.17 Million
Q2 2023 Aug 11, 2023	SELL	$15.3 - $22.61 $103,550 - $153,024	-6,768 Reduced 0.98%	684,133 $10.5 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $965,416 - $1.24 Million	54,176 Added 8.51%	690,901 $15.5 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $84,592 - $119,721	4,580 Added 0.72%	636,725 $13.4 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $100,093 - $125,084	-4,369 Reduced 0.69%	632,145 $15.6 Million
Q2 2022 Aug 12, 2022	BUY	$20.94 - $30.01 $214,718 - $307,722	10,254 Added 1.64%	636,514 $15.4 Million
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $1.66 Million - $2.16 Million	70,464 Added 12.68%	626,260 $16.1 Million
Q4 2021 Feb 08, 2022	SELL	$24.34 - $31.17 $117,294 - $150,208	-4,819 Reduced 0.86%	555,796 $17.3 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $754,527 - $1.45 Million	-58,130 Reduced 9.39%	560,615 $13.6 Million
Q2 2021 Aug 13, 2021	SELL	$14.11 - $26.4 $312,903 - $585,446	-22,176 Reduced 3.46%	618,745 $9.03 Million
Q1 2021 May 12, 2021	BUY	$23.37 - $31.77 $608,180 - $826,782	26,024 Added 4.23%	640,921 $16 Million
Q4 2020 Feb 11, 2021	BUY	$19.17 - $27.87 $11.8 Million - $17.1 Million	614,897 New	614,897 $16.8 Million

Others Institutions Holding TVTX

# of Institutions

192

Shares Held

84.5M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.14B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Travere Therapeutics, Inc. Transaction History